Alvotech ALVO
NASDAQ ALVO
$4.26 +0.27 (+6.63%)
As of: Aug 20, 2026 · 3:58 PM EDT

Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2026)

Alvotech's (ALVO) quarterly Non-Current Deferred Tax Liability came in at $7.2 million in Q1 2026, up 248.1% YoY from $2.1 million in Q1 2025, and down 8.95% on a QoQ basis from $7.9 million in Q4 2025.

Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $7.2 million in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 248.1% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (up 248.1% YoY) and the FY2025 annual result came in at $7.9 million, up 334.46% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $7.2 million in Q1 2026, from $7.9 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $7.9 million in Q4 2025 to a low of $45000.0 in Q2 2023.
  • A 5-year average of $2.4 million and a median of $1.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability plunged 82.85% — and 2024, when it soared 3316.98%.
  • Tracing ALVO's Non-Current Deferred Tax Liability over 5 years: stood at $309000.0 in 2022, then sank by 82.85% to $53000.0 in 2023, then soared by 3316.98% to $1.8 million in 2024, then soared by 334.46% to $7.9 million in 2025, then decreased by 8.95% to $7.2 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $7.2 million (Q1 2026), $7.9 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Alvotech 1.26 Bn 1.26 Bn 5.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.16 Mn
Mar 31, 2026 7.16 Mn
Dec 31, 2025 7.87 Mn
Dec 31, 2025 7.87 Mn
Sep 30, 2025 7.54 Mn
Sep 30, 2025 7.54 Mn
Jun 30, 2025 2.01 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 2.06 Mn
Mar 31, 2025 2.06 Mn
Dec 31, 2024 1.81 Mn
Dec 31, 2024 1.81 Mn
Sep 30, 2024 1.54 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.39 Mn
Jun 30, 2024 1.39 Mn
Mar 31, 2024 1.61 Mn
Mar 31, 2024 1.61 Mn
Dec 31, 2023 53,000.00
Dec 31, 2023 53,000.00